Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04557748 · ClinicalTrials.gov registry record
LURN: Urinary Urgency Phenotyping Protocol
A clinical trial of Lower Urinary Tract Symptoms, sponsored by Arbor Research Collaborative for Health.
- Active
- Registry status
- 840
- Enrollment target
- 6
- Study locations
NCT04557748: Active study of Lower Urinary Tract Symptoms, sponsored by Arbor Research Collaborative for Health.
NCT04557748 is a study of Lower Urinary Tract Symptoms that is active but no longer recruiting, run by Arbor Research Collaborative for Health. The registered enrollment target is 840 participants, above the 710-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (18% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04557748, a study of Lower Urinary Tract Symptoms, is active but no longer recruiting, sponsored by Arbor Research Collaborative for Health.
- ACTIVE NOT RECRUITING
- Registry status
- 840 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to define and characterize important subtypes of patients with urinary urgency to improve our understanding of the pathophysiology, risk factors, experiences, and comorbidities to lay the foundation for more effective treatment by focusing on the most bothersome and difficult to treat symptoms of urinary urgency and urgency urinary incontinence.
Primary Outcome
Participants will be classified as treatment responders if they achieve at least a 10-point reduction from baseline on the OAB-q and/or respond "much better" or "very much better" on the PGI-I
Conditions Studied
Interventions
- OTHER Observational
- OTHER Observational Controls
- OTHER Central Sensitization
- OTHER Physical Activity and Sleep Tracker
- OTHER Physical Activity and Sleep Tracker Controls
Study Locations (6)
Illinois
- Northwestern University - Chicago
Iowa
- University of Iowa - Iowa City
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University in St. Louis - St Louis
North Carolina
- Duke University - Durham
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2026-12 |
What the registry record for NCT04557748 still lists
NCT04557748 is an observational study that tracks outcomes without assigning an intervention. The registered 840 participants enrollment target is mid-sized for trials with a published cap, above the 710-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 5 interventions - of which Observational is the first listed.
NCT04557748 lists 6 locations in 6 states (Illinois, Iowa, Michigan).
Frequently Asked Questions
What is clinical trial NCT04557748 about?
NCT04557748 is a clinical study titled "LURN: Urinary Urgency Phenotyping Protocol". The purpose of this study is to define and characterize important subtypes of patients with urinary urgency to improve our understanding of the pathophysiology, risk factors, experiences, and comorbidities to lay the foundation for more effective treatment by focusing on the most bothersome and diff...
What is the current status of trial NCT04557748?
This trial is currently active not recruiting. The enrollment target is 840 participants. The study started on 2021-02-17. Estimated completion is 2026-12.
What conditions does trial NCT04557748 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT04557748?
The interventions under investigation include: Observational (OTHER), Observational Controls (OTHER), Central Sensitization (OTHER), Physical Activity and Sleep Tracker (OTHER), Physical Activity and Sleep Tracker Controls (OTHER).
Who is sponsoring clinical trial NCT04557748?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04557748 being conducted?
This trial has 6 study locations across Illinois, Iowa, Michigan, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04557748's enrollment target sits among peer trials
840 4th of 21 higher than 18 of 21 other Lower Urinary Tract Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lower Urinary Tract Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
US Imaging for the Assessment of LUTS
RECRUITING
-
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
RECRUITING · Phase 2
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
BPH Global Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04831580 · 840 participants · NA
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- NCT04976881 · 840 participants · NA
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- NCT04985903 · 840 participants · NA
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
- NCT05384626 · 840 participants · Phase 1
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI